{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-032271","form_type":"8-K","ticker":"PLSE","cik":"0001625101","company_name":"PULSE BIOSCIENCES, INC.","filed_at":"2026-10-07T13:06:30+00:00","discovered_at":"2026-10-07T13:07:00.096448+00:00","generated_at":"2026-10-12T15:57:33.307982+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Pulse Biosciences hits 164-patient enrollment target in NANOPULSE-AF pivotal AF trial, 3 months early","bullets":["NANOPULSE-AF IDE pivotal study enrolled 164 evaluable patients across 15 clinical sites, evaluating the nPulse Cardiac Catheter System in drug-resistant, symptomatic paroxysmal atrial fibrillation.","Enrollment completed three months ahead of the original 9-month timeline; first patients were treated in April 2026, starting at St. Bernards Medical Center in Jonesboro, Arkansas.","Primary safety and effectiveness endpoints will be assessed at 6 and 12 months post-ablation; Pulse expects to present pivotal data at a future medical society conference.","Vivek Reddy, MD (Mount Sinai Fuster Heart Hospital) serves as national principal investigator; Devi Nair, MD led the first case; CMO David Kenigsberg credited investigator enthusiasm for the pace."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-032271","json":"https://secwatch.observer/filing/0001437749-26-032271.json","markdown":"https://secwatch.observer/filing/0001437749-26-032271.md","text":"https://secwatch.observer/filing/0001437749-26-032271.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926032271/0001437749-26-032271-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926032271/plse20261002_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T15:57:33.307982+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}